UA89330U - Method for preventing inflammatory syndrome of immunity restoration in hiv-infected patients with cerebral toxoplasmosis - Google Patents

Method for preventing inflammatory syndrome of immunity restoration in hiv-infected patients with cerebral toxoplasmosis

Info

Publication number
UA89330U
UA89330U UAU201315075U UAU201315075U UA89330U UA 89330 U UA89330 U UA 89330U UA U201315075 U UAU201315075 U UA U201315075U UA U201315075 U UAU201315075 U UA U201315075U UA 89330 U UA89330 U UA 89330U
Authority
UA
Ukraine
Prior art keywords
hiv
restoration
immunity
infected patients
toxoplasmosis
Prior art date
Application number
UAU201315075U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Анатолій Іванович Гоженко
Віктор Степанович Гойдик
Наталія Сергіївна Гойдик
Original Assignee
Анатолій Іванович Гоженко
Віктор Степанович Гойдик
Наталія Сергіївна Гойдик
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Анатолій Іванович Гоженко, Віктор Степанович Гойдик, Наталія Сергіївна Гойдик filed Critical Анатолій Іванович Гоженко
Priority to UAU201315075U priority Critical patent/UA89330U/en
Publication of UA89330U publication Critical patent/UA89330U/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for preventing the inflammatory syndrome of immunity restoration in HIV-infected patients with cerebral toxoplasmosis provides for therapy of toxoplasmosis using combination of antibiotics, sulfanilamides, anti-inflammatory drugs, hormonal drugs, active antiretroviral drugs as well as detoxifying and dehydration therapy. The therapy of toxoplasmosis continues for 14-21 days from the beginning of antiretroviral therapy.
UAU201315075U 2013-12-23 2013-12-23 Method for preventing inflammatory syndrome of immunity restoration in hiv-infected patients with cerebral toxoplasmosis UA89330U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201315075U UA89330U (en) 2013-12-23 2013-12-23 Method for preventing inflammatory syndrome of immunity restoration in hiv-infected patients with cerebral toxoplasmosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201315075U UA89330U (en) 2013-12-23 2013-12-23 Method for preventing inflammatory syndrome of immunity restoration in hiv-infected patients with cerebral toxoplasmosis

Publications (1)

Publication Number Publication Date
UA89330U true UA89330U (en) 2014-04-10

Family

ID=56267490

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201315075U UA89330U (en) 2013-12-23 2013-12-23 Method for preventing inflammatory syndrome of immunity restoration in hiv-infected patients with cerebral toxoplasmosis

Country Status (1)

Country Link
UA (1) UA89330U (en)

Similar Documents

Publication Publication Date Title
MX2020009780A (en) Autotaxin inhibitor compounds.
MX2015009105A (en) Solid solution compositions and use in chronic inflammation.
MX366317B (en) Compositions and methods for treating chronic inflammation and inflammatory diseases.
MY188139A (en) Sodium channel modulators for the treatment of pain
MX2017008386A (en) Site specific dosing of a btk inhibitor.
MX2015016100A (en) Cryopyrin inhibitors for preventing and treating inflammation.
PH12017500933A1 (en) Sublingual administration of riluzole
MX2015009045A (en) Compositions and methods for treating severe pain.
IN2013MU00711A (en)
PH12017500934A1 (en) Sublingual formulation of riluzole
PH12016500863A1 (en) Tetracyclic autotaxin inhibitors
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
EP4356962A3 (en) Selective il-6-trans-signalling inhibitor compositions
MX2016005545A (en) Human relaxin analogue, pharmaceutical composition of same, and pharmaceutical application of same.
NZ726131A (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2014014814A (en) Pharmaceutical composition for treating inflammation and pain.
MX2016011706A (en) Progesterone formulations.
MX370957B (en) Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis.
GB2527233A (en) Composition comprising hydrocortisone
UA89330U (en) Method for preventing inflammatory syndrome of immunity restoration in hiv-infected patients with cerebral toxoplasmosis
IN2013MU03428A (en)
MX2017012449A (en) Pain treatment.
PH12020500472A1 (en) Autotaxin inhibitor compounds
MX2016010919A (en) 4-benzylsulfonyl-2-butenenitrile.
UA88055U (en) Method for treating chronic periodontitis